AIS
ABBV icon

Advocate Investing Services’s AbbVie ABBV Stock Holding History

Advocate Investing Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Buy
596
+1
+0.2% +$215 0.12% 112
2026
Q1 		$129K Hold
595
– – 0.11% 112
2025
Q4 		$136K Buy
+595
New +$136K 0.12% 104

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Advocate Investing Services's ABBV Position: Q2 2026 in Review

Advocate Investing Services increased its AbbVie (ABBV) stake by 0.17% in Q2 2026, buying an estimated $215 and bringing the position to 596 shares worth $150K. The position accounts for 0.12% of the portfolio, ranked #112.

Advocate Investing Services first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Advocate Investing Services held 596 shares of AbbVie worth $150K as of Q2 2026.
  • Advocate Investing Services bought 1 AbbVie share in Q2 2026, an estimated $215.
  • AbbVie made up 0.12% of Advocate Investing Services's portfolio in Q2 2026, its #112 holding.
  • Advocate Investing Services first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Advocate Investing Services's 13F filing for Q2 2026, filed 29 Jul 2026.